LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum]

This article refers to:

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling

Wang Q, Liao J, He Z, et al. Onco Targets Ther. 2020;13:10983–10994

On page 10993, Funding section, “This study was supported by grants from the Natural Science Foundation of Fujian Province (grant nos. 2017J01261 and 2016JD1488)” should have been “This study was supported by grants from the Natural Science Foundation of Fujian Province (grant nos. 2017J01261 and 2016J01488)”.

The authors apologize for this error.